BIOPROCESSING WHITE PAPERS

• Transitioning From Using RUO To cGMP Chemicals For Clinical Trials

  Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.

• The Advantages Of A Blended Learning Approach In Operator Training

  5/30/2024

  Explore blended learning and its advantages over traditional operator training methods, which often reduce training to a repetitive but necessary checklist of reading and acknowledging procedures.

• Characterize T Cell Exhaustion And Hypofunctionality In Cancer

  7/31/2023

  Investigate what drives the hypofunctional state of T cells in ICB-nonresponsive cancers through the characterization of CD8+ T cell functionality in different tumor types. 

• Overcoming Efficiency And Quality Challenges In Gene Therapy Development

  10/8/2024

  Review the importance of collaboration and innovation in addressing the challenges with scaling up gene therapy production, from adopting new cell lines to integrating AI in process optimization.

• Centrifuges Transforming Biopharmaceutical Development And Manufacturing

  5/23/2023

  Single-use centrifuges have the potential to become the new bioprocessing standard, helping manufacturers meet the need for innovative production methods when facing emerging modalities and next-generation biotherapeutics at scale.

• Response To FDA Black Box Warning

  3/1/2024

  The FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies. Review the key points of this announcement concerning the CGT research community.